Skip to main content
. 2022 Jan 4;10(3):553–563. doi: 10.14218/JCTH.2021.00250

Fig. 1. Rationale for neoadjuvant and adjuvant therapy in ICC.

Fig. 1

AT, adjuvant therapy; ICC, intrahepatic cholangiocarcinoma; NAT, neoadjuvant therapy.